STRS Ohio’s Vaxcyte PCVX Stock Holding History

STRS Ohio’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.18M	Buy	37,500 +6,700	+22%	+$364K	0.01%	542
2026 Q1	$1.79M	Buy	30,800 +20,500	+199%	+$1.11M	0.01%	592
2025 Q4	$475K	Sell	10,300 -1,700	-14%	-$76K	﹤0.01%	1126
2025 Q3	$432K	Sell	12,000 -5,900	-33%	-$195K	﹤0.01%	1167
2025 Q2	$582K	Buy	17,900 +1,300	+8%	+$42.6K	﹤0.01%	1158
2025 Q1	$627K	Sell	16,600 -1,800	-10%	-$144K	﹤0.01%	1046
2024 Q4	$1.51M	Sell	18,400 -7,100	-28%	-$705K	0.01%	723
2024 Q3	$2.91M	Buy	25,500 +1,800	+8%	+$162K	0.01%	539
2024 Q2	$1.79M	Sell	23,700 -1,500	-6%	-$102K	0.01%	643
2024 Q1	$1.72M	Buy	25,200 +14,500	+136%	+$1M	0.01%	696
2023 Q4	$671K	Buy	10,700 +400	+4%	+$20.8K	﹤0.01%	1089
2023 Q3	$525K	Hold	10,300	–	–	﹤0.01%	1230
2023 Q2	$514K	Buy	10,300 +6,300	+158%	+$299K	﹤0.01%	1272
2023 Q1	$149K	Hold	4,000	–	–	﹤0.01%	1661
2022 Q4	$191K	Buy	+4,000	New	+$157K	﹤0.01%	1603
2022 Q2	–	Sell	-5,100	Closed	-$123K	–	2220
2022 Q1	$123K	Hold	5,100	–	–	﹤0.01%	1806
2021 Q4	$121K	Hold	5,100	–	–	﹤0.01%	1861
2021 Q3	$129K	Hold	5,100	–	–	﹤0.01%	1889
2021 Q2	$114K	Buy	5,100 +500	+11%	+$10.2K	﹤0.01%	1946
2021 Q1	$90K	Hold	4,600	–	–	﹤0.01%	1964
2020 Q4	$122K	Hold	4,600	–	–	﹤0.01%	1852
2020 Q3	$227K	Buy	+4,600	New	+$183K	﹤0.01%	1630

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

STRS Ohio's PCVX Position: Q2 2026 in Review

STRS Ohio increased its Vaxcyte (PCVX) stake by 22% in Q2 2026, buying an estimated $364K and bringing the position to 37,500 shares worth $2.18M. The position accounts for 0.01% of the portfolio, ranked #542.

STRS Ohio first reported a position in PCVX in Q3 2020 and has held it in 22 quarters since. The position peaked at $2.91M in Q3 2024. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

STRS Ohio held 37,500 shares of Vaxcyte worth $2.18M as of Q2 2026.
STRS Ohio bought 6,700 Vaxcyte shares in Q2 2026, an estimated $364K.
Vaxcyte made up 0.01% of STRS Ohio's portfolio in Q2 2026, its #542 holding.
STRS Ohio first reported a position in Vaxcyte in Q3 2020 and has held it in 22 quarters since.
STRS Ohio's Vaxcyte position peaked at $2.91M in Q3 2024.
332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.